Treating Seizures and Improving Newborn Outcomes for Infants with Hypoxic-Ischemic Encephalopathy

Area of Science:

• Neonatal neurology
• Neurocritical care
• Pediatric epilepsy

Background:

• Hypoxic-ischemic encephalopathy (HIE) is a leading cause of seizures in newborns.
• Subclinical seizures are common in HIE, necessitating continuous monitoring.
• Early intervention in neonatal seizures is crucial for improving long-term neurodevelopmental outcomes.

Purpose of the Study:

• To summarize current guidelines for managing neonatal seizures.
• To highlight the role of electroencephalographic monitoring and pharmacotherapy.
• To emphasize the importance of follow-up for epilepsy and neurodevelopmental screening.

Main Methods:

• Review of International League Against Epilepsy (ILAE) guidelines.
• Analysis of current practices in neonatal seizure management.
• Synthesis of evidence regarding treatment efficacy and outcomes.

Main Results:

• Phenobarbital is the recommended first-line treatment for neonatal seizures.
• Early discontinuation of antiseizure medications is advised after acute provoked seizures resolve.
• Continuous electroencephalographic monitoring is essential for detecting subclinical seizures.

Conclusions:

• Prompt diagnosis and treatment of neonatal seizures, particularly those associated with HIE, are vital.
• Adherence to ILAE guidelines on phenobarbital use and medication discontinuation is recommended.
• Long-term neurodevelopmental follow-up and epilepsy screening are necessary for affected infants.